R. Paz

发表

Single nucleotide polymorphism array karyotyping: A diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing

L. Arenillas, F. Solé, M. Tormo, 2013, Genes, chromosomes & cancer.

Distinctive patterns of naïve/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP‐70 B‐chronic lymphocytic patients

C. Martínez-A, M. Álvarez-Mon, J. Monserrat, 2013, Cytometry. Part B, Clinical cytometry.

A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control

M. Terol, A. Órfão, A. Oriol, 2013, Leukemia.

Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival

M. Tormo, Marcos González, N. Puig, 2012, Annals of Hematology.

Independent Impact of Iron Overload and Transfusion Dependency on Survival and Leukemic Evolution in Patients with Myelodysplastic Syndrome

L. Arenillas, M. Tormo, J. Cervera, 2008 .

Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients

M. Terol, A. Órfão, E. Dı́az-Rodrı́guez, 2012, Leukemia.

Thalidomide/Dexamethasone (TD) Vs. Bortezomib(Velcade®)/Thalidomide/Dexamethasone (VTD) Vs. VBMCP/VBAD/Velcade® As Induction Regimens Prior Autologous Stem Cell Transplantation (ASCT) in Younger Patients with Multiple Myeloma (MM): First Results of a Prospective Phase III PETHEMA/Gem Trial

M. Terol, J. Miguel, A. Oriol, 2008 .

A phase 2, randomized, double‐blind, multicenter study comparing siltuximab plus best supportive care (BSC) with placebo plus BSC in anemic patients with International Prognostic Scoring System low‐ or intermediate‐1–risk myelodysplastic syndrome

G. Garcia-Manero, D. Steensma, R. Komrokji, 2014, American journal of hematology.

The Presence of MDS-like Phenotypic Abnormalities (MDS-PA) Identifies Newly Diagnosed Multiple Myeloma (MM) Patients with MDS/AML-Related Somatic Mutations and Inferior Survival

F. Prósper, Marcos González, J. Miguel, 2016 .

Safety and ef ﬁ cacy of asciminib treatment in chronic myeloid leukemia patients in real-life clinical practice

M. Ramírez, A. Rosell, F. Sánchez-Guijo, 2021 .

Immediate Effects of Dasatinib on the Migration and Redistribution of Naïve and Memory Lymphocytes Associated With Lymphocytosis in Chronic Myeloid Leukemia Patients

C. Muñoz‐Calleja, A. Kreutzman, F. Sánchez-Guijo, 2019, Front. Pharmacol..

A Prospective, Multicenter, Randomized, Trial of Bortezomib/Melphalan/Prednisone (VMP) Versus Bortezomib/Thalidomide/Prednisone (VTP) as Induction Therapy Followed by Maintenance Treatment with Bortezomib/Thalidomide (VT) Versus Bortezomib/Prednisone (VP) in Elderly Untreated Patients with Multiple

M. Terol, A. Oriol, N. Gutiérrez, 2009 .

Identification of Poor Risk Patients in Low and Intermediate-1 (Int-1) IPSS MDS with the New Ipssr Index and Comparison with Other Prognostic Indexes. A Study by the Spanish Group of MDS (GESMD)

M. Tormo, S. Brunet, J. Bargay, 2012 .

Multivariate time‐dependent comparison of the impact of lenalidomide in lower‐risk myelodysplastic syndromes with chromosome 5q deletion

M. Tormo, S. Brunet, J. Bargay, 2014, British Journal of Haematology.

A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control

M. Terol, A. Órfão, A. Oriol, 2013, Leukemia.

Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry

M. Tormo, S. Brunet, J. Bargay, 2015, Leukemia.

Fecal calprotectin in allogeneic stem cell transplantation for the diagnosis of acute intestinal graft versus host disease

M. V. Domselaar, D. Gallardo, R. Paz, 2012, Bone Marrow Transplantation.

Effect of the Terminal Complement Inhibitor Eculizumab on Patient Reported Outcomes in Paroxysmal Nocturnal Hemoglobinuria (PNH): Phase III Triumph Study Results.

D. Cella, A. Zanella, U. Dührsen, 2006 .

Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications

G. Sanz, Á. Remacha, B. Arrizabalaga, 2015, Annals of Hematology.

Safety and Efficacy Profile of Asciminib As Treatment in Chronic Myeloid Leukemia Patients after Several Tyrosine-Kinase Inhibitors Failure

M. Ramírez, A. Rosell, F. Sánchez-Guijo, 2020 .

Bortezomib (Velcade)-Melphalan-Prednisone (VMP) Versus Velcade- Thalidomide-Prednisone (VTP) in Elderly Untreated Multiple Myeloma Patients: Which Is the Best Partner for Velcade: An Alkylating or An Immunomodulator Agent?

M. Terol, J. Miguel, A. Oriol, 2008 .

Darbepoetin Alfa for the Treatment of Anemia in Patients with Myelodysplastic Syndrome.

M. Tormo, P. Giraldo, B. Nomdedeu, 2005 .

Analysis of Immunophenotypic Response (IR) by Multiparameter Flow Cytometry In 516 Myeloma Patients Included In Three Consecutive Spanish Trials

M. Terol, J. Miguel, A. Oriol, 2010 .

Fecal Calprotectin In Allogeneic Stem Cell Trasplantation as Surrogate Marker of Gastrointestinal Graft Versus Host Disease

D. Gallardo, J. Nieto, R. Paz, 2010 .

Improvement in Fatigue With Eculizumab Treatment of Patients With Paroxysmal Nocturnal Hemoglobinuria (pnh) Occurs Independent of Changes in Anemia

D. Cella, A. Zanella, A. Risitano, 2008 .

Outcomes of Chronic Myeloid Leukemia (CML) Patients Who Stopped Second Generation Tyrosine Kinase Inhibitors (2GTKIs) As Second Line Treatment. Results of the CML Spanish National Registry (RELMC)

M. Requena, C. Burgaleta, P. Giraldo, 2012 .

Haploidentical IL-15/41BBL activated and expanded natural killer cell infusion therapy after salvage chemotherapy in children with relapsed and refractory leukemia.

A. Balas, J. Torres, J. Martínez-López, 2018, Cancer letters.

Single nucleotide polymorphism array karyotyping: A diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing

L. Arenillas, F. Solé, M. Tormo, 2013, Genes, chromosomes & cancer.